Published in N Engl J Med on July 04, 1968
The mechanics of esophageal muscle contraction. Evidence of an inotropic effect of gastrin. J Clin Invest (1973) 1.00
Action and therapeutic potential of oxyntomodulin. Mol Metab (2013) 0.98
Left ventricular function in acute myocardial infarction. J Clin Invest (1971) 0.95
Effects of experimental heart failure on the capacity of glucagon to augment myocardial contractility and activate adenyl cyclase. J Clin Invest (1970) 0.94
Hemodynamic responses to glucagon: an experimental study of central, visceral and peripheral effects. Ann Surg (1970) 0.92
Metabolic and hormonal effects of glucagon infusion in erythroblastotic infants. Arch Dis Child (1973) 0.89
Cutaneous sensory function in diabetes mellitus. J Neurol Neurosurg Psychiatry (1979) 0.83
Calcium channel antagonist and beta-blocker overdose: antidotes and adjunct therapies. Br J Clin Pharmacol (2015) 0.81
Effect of glucagon on infants and children with atrioventricular heart block. Br Heart J (1973) 0.78
Comparison of the inotropic response to glucagon, ouabain and noradrenaline. Br J Pharmacol (1970) 0.77
Haemodynamic effects of glucagon during acute myocardial infarction with left ventricular failure in man. Br Heart J (1971) 0.77
Effect of glucagon on ventricular arrhythmias after coronary artery occlusion and on ventricular automaticity in the dog. Br J Pharmacol (1971) 0.76
Effects of glucagon on resting and exercise haemodynamics in patients with coronary heart disease. Br Heart J (1972) 0.75
[Hemodynamic effect of glucagon on the intact dog heart]. Arch Kreislaufforsch (1971) 0.75
Improved cardiovascular effects of glucagon in dogs with endotoxin shock. Ann Surg (1972) 0.75
Glucagon and heart in type 2 diabetes: new perspectives. Cardiovasc Diabetol (2016) 0.75
Glucagon and the heart. Br Med J (1969) 0.75
[Myocardial metabolism under intravenous infusion of glucagon (author's transl)]. Basic Res Cardiol (1975) 0.75
Passive smoking and heart disease. Epidemiology, physiology, and biochemistry. Circulation (1991) 7.94
Fiber orientation in the canine left ventricle during diastole and systole. Circ Res (1969) 7.01
Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest (1996) 3.42
Structural basis of end-stage failure in ischemic cardiomyopathy in humans. Circulation (1994) 3.24
Passive smoking and heart disease. Mechanisms and risk. JAMA (1995) 3.23
Glucagon. Its enhancement of cardiac performance in the cat and dog and persistence of its inotropic action despite beta-receptor blockade with propranolol. Circ Res (1968) 2.69
Influence of the thyroid state on the intrinsic contractile properties and energy stores of the myocardium. J Clin Invest (1967) 2.51
Assessment of passive elastic stiffness for isolated heart muscle and the intact heart. Circ Res (1973) 2.42
Effects of vesnarinone on morbidity and mortality in patients with heart failure. Vesnarinone Study Group. N Engl J Med (1993) 2.39
Oxygen consumption of the heart. Newer concepts of its multifactoral determination. Am J Cardiol (1968) 2.29
Assessment of cardiac contractility. The relation between the rate of pressure rise and ventricular pressure during isovolumic systole. Circulation (1971) 2.15
Velocity of contraction as a determinant of myocardial oxygen consumption. Am J Physiol (1965) 2.11
Hemodynamic and metabolic responses to vasodilator therapy in acute myocardial infarction. Circulation (1973) 2.08
Left ventricular volume from paired biplane two-dimensional echocardiography. Circulation (1979) 2.08
Pharmacy madness. J Am Coll Cardiol (2000) 2.03
Report of the National Heart, Lung, and Blood Institute Special Emphasis Panel on Heart Failure Research. Circulation (1997) 2.00
Stretch-induced programmed myocyte cell death. J Clin Invest (1995) 1.99
Control of myocardial oxygen consumption: relative influence of contractile state and tension development. J Clin Invest (1968) 1.90
Myocyte cell loss and myocyte cellular hyperplasia in the hypertrophied aging rat heart. Circ Res (1990) 1.89
Side-to-side slippage of myocytes participates in ventricular wall remodeling acutely after myocardial infarction in rats. Circ Res (1990) 1.85
Vasodilator treatment for acute and chronic heart failure. Br Heart J (1977) 1.84
Ischemic cardiomyopathy: pathophysiologic mechanisms. Prog Cardiovasc Dis (1990) 1.82
Stress distribution in the canine left ventricle during diastole and systole. Biophys J (1970) 1.76
Contractile state of cardiac muscle obtained from cats with experimentally produced ventricular hypertrophy and heart failure. Circ Res (1967) 1.75
Diastolic pressure-volume relationship in the canine left ventricle. Circ Res (1971) 1.74
Treatment of chronic congestive heart failure with captopril, an oral inhibitor of angiotensin-converting enzyme. N Engl J Med (1979) 1.73
Myocyte nuclear and possible cellular hyperplasia contribute to ventricular remodeling in the hypertrophic senescent heart in humans. J Am Coll Cardiol (1994) 1.69
The role of vasodilator therapy in heart failure. Prog Cardiovasc Dis (1977) 1.69
Passive smoking increases experimental atherosclerosis in cholesterol-fed rabbits. J Am Coll Cardiol (1993) 1.68
Effects of exercise on myocardial force-velocity relations in intact unanesthetized man: relative roles of changes in heart rate, sympathetic activity, and ventricular dimensions. J Clin Invest (1965) 1.67
Even a little secondhand smoke is dangerous. JAMA (2001) 1.65
The cellular basis of dilated cardiomyopathy in humans. J Mol Cell Cardiol (1995) 1.64
Cellular basis of chronic ventricular remodeling after myocardial infarction in rats. Circ Res (1991) 1.63
Effects of isometric exercise on cardiac performance. The grip test. Circulation (1971) 1.63
The influence of left ventricular filling pressure on atrial contribution to cardiac output. Am Heart J (1979) 1.63
Long-term digitalis therapy improves left ventricular function in heart failure. N Engl J Med (1980) 1.63
Relief of angina pectoris by electrical stimulation of the carotid-sinus nerves. N Engl J Med (1967) 1.61
Relation between mechanics of contraction and relaxation in mammalian cardiac muscle. Am J Physiol (1969) 1.60
Thallium-20 1 myocardial perfusion scintigraphy for the clinical clarification of normal, abnormal and equivocal electrocardiographic stress tests. Am J Cardiol (1978) 1.60
Mechanisms of contraction of the normal and failing heart. N Engl J Med (1967) 1.57
Relation of ultrastructure to function in the intact heart: sarcomere structure relative to pressure volume curves of intact left ventricles of dog and cat. Circ Res (1966) 1.56
Alterations in left ventricular function and coronary hemodynamics with captopril, hydralazine and prazosin in chronic ischemic heart failure: a comparative study. Circulation (1982) 1.54
The heart as a suction pump. Sci Am (1986) 1.52
Series elasticity in heart muscle. Its relation to contractile element velocity and proposed muscle models. Circ Res (1967) 1.52
Myocyte death in streptozotocin-induced diabetes in rats in angiotensin II- dependent. Lab Invest (2000) 1.51
Amrinone: a new non-glycosidic, non-adrenergic cardiotonic agent effective in the treatment of intractable myocardial failure in man. Circulation (1979) 1.47
Effects of hypoxia on mechanics of cardiac contraction. Am J Physiol (1970) 1.47
Position report on cardiac rehabilitation. Recommendations of the American College of Cardiology. J Am Coll Cardiol (1986) 1.45
Altered myocardial mechanics in diabetic rats. Circ Res (1980) 1.43
Treatment of angina pectoris by electrical stimulation of the carotid-sinus nerves. N Engl J Med (1969) 1.43
Myocardial micronecrosis produced by microsphere embolization. Role of an alpha-adrenergic tonic influence on the coronary microcirculation. Circ Res (1984) 1.43
Length-dependent changes in myocardial contractile state. Am J Physiol (1973) 1.43
Microvascular spasm in the cardiomyopathic Syrian hamster: a preventable cause of focal myocardial necrosis. Circulation (1982) 1.41
Interstudy reproducibility of dimensional and functional measurements between cine magnetic resonance studies in the morphologically abnormal left ventricle. Am Heart J (1990) 1.40
The architecture of the heart in systole and diastole. Technique of rapid fixation and analysis of left ventricular geometry. Circ Res (1967) 1.40
The noninvasive diagnosis of right ventricular infarction. Circulation (1978) 1.39
Full disclosure: the antidote to conflict of interest. J Am Coll Cardiol (2000) 1.39
The editorial process. J Am Coll Cardiol (1993) 1.39
Depression of myocardial contractility in rats by free fatty acids during hypoxia. Circ Res (1970) 1.38
Clinical practice guidelines. Does the cookbook have enough recipes? JAMA (1994) 1.38
Studies on cardiac dimensions in intact unanesthetized man. V. Effects of nitroglycerin. Circulation (1965) 1.38
Circulatory effects of electrical stimulation of the carotid sinus nerves in man. Circulation (1969) 1.38
Primary angioplasty and thrombolysis for acute myocardial infarction: an evidence summary. J Am Coll Cardiol (1996) 1.37
Cellular basis for volume related wall thickness changes in the rat left ventricle. J Mol Cell Cardiol (1974) 1.36
Beneficial effects of vasodilator agents in severe mitral regurgitation due to dysfunction of subvalvar apparatus. Circulation (1973) 1.36
beta-adrenergic stimulation causes cardiocyte apoptosis: influence of tachycardia and hypertrophy. Am J Physiol (1998) 1.35
Factors which affect the diastolic pressure-volume curve. Circ Res (1978) 1.35
Sustained hemodynamic and clinical effects of a new cardiotonic agent, WIN 47203, in patients with severe congestive heart failure. Circulation (1983) 1.33
Dependence of ventricular distensibility on filling of the opposite ventricle. Am J Physiol (1967) 1.33
Application of transesophageal echocardiography to continuous intraoperative monitoring of left ventricular performance. Am J Cardiol (1980) 1.32
Diastolic geometry and sarcomere lengths in the chronically dilated canine left ventricle. Circ Res (1971) 1.32
The ultrastructure of the heart in systole and diastole. Chantes in sarcomere length. Circ Res (1967) 1.32
The cardiac hypertrophy process. Analyses of factors determining pathological vs. physiological development. Circ Res (1979) 1.31
Oral hydralazine therapy for chronic refractory heart failure. Circulation (1976) 1.30
Myocardial mechanics in ppillary muscles of the rat and cat. Am J Physiol (1969) 1.30
Beneficial effects of amrinone-hydralazine combination on resting hemodynamics and exercise capacity in patients with severe congestive heart failure. Circulation (1981) 1.28
Depression of left ventricular function due to acute myocardial ischemia and its reversal after aortocoronary saphenous-vein bypass. N Engl J Med (1972) 1.27
Influence of direct myocardial revascularization on left ventricular asynergy and function in patients with coronary heart disease. With and without previous myocardial infarction. Circulation (1973) 1.26
Detection of residual myocardial function in coronary artery disease using post-extra systolic potentiation. Circulation (1974) 1.25
Absence of a lateral border zone of intermediate creatine phosphokinase depletion surrounding a central infarct 24 hours after acute coronary occlusion in the dog. Circ Res (1977) 1.25
Maximal rate of pressure fall (peak negative dP-dt) during ventricular relaxation. Cardiovasc Res (1972) 1.25
Clinical and morphological features of human hypertensive-diabetic cardiomyopathy. Am Heart J (1980) 1.24
An intrinsic neuromuscular basis for mitral valve motion in the dog. Circ Res (1967) 1.24
Norepinephrine stores and contractile force of papillary muscle from the failing human heart. Circulation (1966) 1.23
Redistribution of collateral blood flow from necrotic to surviving myocardium following coronary occlusion in the dog. Circ Res (1976) 1.23
Comparative myocardial depressant and anti-arrhythmic properties of d-propranolol, dl-propranolol and quinidine. J Pharmacol Exp Ther (1967) 1.22
Influence of caffeine on force development and force-frequency relations in cat and rat heart muscle. Cardiovasc Res (1974) 1.22
Comparison of the force-velocity relation and the ventricular function curve as measures of the contractile state of the intact heart. Circ Res (1966) 1.22
Diabetic cardiomyopathy. Prog Cardiovasc Dis (1985) 1.22
Dynamic geometry of the left ventricle in mitral regurgitation. Circulation (1973) 1.22
In-vitro studies of myocardial asynchrony and regional hypoxia. Circ Res (1969) 1.22